Date | Title | Description | |
---|---|---|---|
24 Feb 2021 | About corporate governance | The Company informs about the agreements adopted by the Board of Directors | Download |
27 Nov 2020 | On business and financial situation | The Company publishes the results of the PRISMA-3 study of the efficacy and safety of Doria® in schizophrenic patients in the journal npj Schizophrenia | Download |
09 Jul 2020 | On business and financial situation | ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate | Download |
Pages
Date | Title | Description | |
---|---|---|---|
24 Feb 2021 | Annual Corporate Governance Report | ROVI releases the 2020 Annual Corporate Governance Report | Download |
24 Feb 2021 | Annual Report regarding remuneration of the members of the Board of Directors | ROVI releases the 2020 annual report regarding remuneration of the members of the Board of Directors | Download |
24 Feb 2021 | On business and financial situation | The company releases the press release related to 2020 financial results | Download |
11 Jan 2021 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the fourth quarter of 2020 | Download |
24 Nov 2020 | On business and financial situation | The Company releases the presentation related to its strategy update because of the 2020 Capital Markets Day. | Download |
Pages
Date | Title | Description | |
---|---|---|---|
21 Feb 2013 | Información sobre resultados (2) | Download | |
21 Feb 2013 | Información sobre resultados | Download | |
21 Feb 2013 | Informe Anual de Gobierno Corporativo 2012 | Download | |
08 Nov 2012 | Información financiera intermedia | Download | |
08 Nov 2012 | Información sobre resultados | Download |